Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Intracameral Moxifloxacin vs Levofloxacin in Cataract Surgery
NCT05741632Phase 1Completed
- Sponsor
- Universitas Indonesia
- Start
- Feb 2023
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of Moxisurge in cataract (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Endothelial cell density at 1 month. Started Feb 2023; status: completed.
02
Drugs
Moxisurge
03
Conditions
cataract
Beyond the preview
Go deeper on NCT05741632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05741632.